FUJIFILM Diosynth Biotechnologies has announced an expansion of its operations, a move that marks a pivotal moment in its journey as a leader in pharmaceuticals.
The success of the UK’s energy transition will rely on collaboration between businesses to maintain a robust supply chain, a global energy specialist has warned following the launch of its latest research.
Mytos has entered into a manufacturing collaboration with Aspen Neuroscience to automate the manufacturing of autologous dopaminergic neuronal precursor cells (DANPCs) for ANPD001, Aspen’s investigational cell therapy program for Parkinson’s disease.
23andMe Holding has announced the launch of Discover23, a new research offering enabling authorised collaborators to securely access to the power and diversity of the 23andMe research cohort.
Antag Therapeutics, a biopharmaceutical company pioneering novel treatments for obesity, has announced the appointment of Joerg Moeller, MD, PhD, as chief executive officer, effective immediately.
Pharmapack Europe & CPHI have outlined key trends for pharma in 2025, highlighting the return of funding liquidity—via increased VC investments and PE capital for M&A.
Join thousands of industry professionals at INTERPHEX, the premier pharmaceutical and biotechnology event taking place 1-3 April 2025, at the Javits Center in NYC.
Flow control specialist Bürkert has developed a flowmeter that uses Surface Acoustic Wave (SAW) technology that also helps to prevent the formation of biofilms in Water for Injection (WFI) loops.
New research released ahead of Pharmapack Europe has ranked the Basel region as the most attractive destination in Europe for launching a new drug device company.
GEODIS, specialist in transport and logistics, announces the appointment of Marc Vollet as executive vice-president of GEODIS’s European Road Network Line of Business.
Molex, a parent to Phillips Medisize, announced that it has completed, through an affiliate, the previously announced acquisition of Vectura Group from Vectura Fertin Pharma, a subsidiary of Philip Morris International.
